--- title: "Outlook Therapeutics (OTLK.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/OTLK.US/norm.md" symbol: "OTLK.US" name: "Outlook Therapeutics" parent: "https://longbridge.com/en/quote/OTLK.US.md" datetime: "2026-06-14T01:35:24.816Z" locales: - [en](https://longbridge.com/en/quote/OTLK.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/OTLK.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/OTLK.US/norm.md) --- # Outlook Therapeutics (OTLK.US) — Financial Reports ## Income Statement (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.0544 | -0.3830 | -0.2831 | -0.5500 | -1.50 | | ROE | 52.74% | 260.78% | 153.28% | 231.46% | 448.15% | | Revenue | 127439.00 | -1.21M | -91787.00 | 1.51M | - | | Net income | -4.45M | -23.06M | -13.29M | -20.15M | -46.36M | | Operating income | -14.03M | -13.48M | -17.31M | -15.75M | -12.39M | | Gross margin | -17.18% | 102.45% | -22000.47% | -403.18% | - | | Net margin | -3494.28% | 1909.05% | 14482.19% | -1338.75% | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 21.89M | 18.24M | 18.58M | 22.39M | 19.08M | | Leverage | -0.7550 | -0.4731 | -0.5774 | -0.6021 | -0.5876 | | BVPS | -0.2772 | -0.5971 | -0.5973 | -0.8553 | -0.9865 | | Turnover | 0.0163 | 0.0117 | 0.0596 | 0.0433 | - | | Cash & STI | 7.75M | 8.68M | 8.08M | 8.90M | 7.56M | | Inv & Rec | 3.34M | 3.46M | 3.34M | 4.13M | 3.60M | | LT assets | 198975.00 | 212413.00 | 225508.00 | 238266.00 | 250699.00 | | Net debt | 19.44M | 28.22M | 22.11M | 25.80M | 25.76M | ## Cash Flow Statement (USD) | Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -7.83M | -14.94M | -12.38M | -11.90M | -16.58M | | Investing CF | - | - | - | - | - | | Financing CF | 6.90M | 15.53M | 11.56M | 13.25M | 18.44M | | Free CF | -2.00M | -10.17M | -7.71M | -5.42M | -10.97M | | OCF coverage | -46.05% | - | -532.22% | -1312.18% | -50.39% | | Repaid & issued | 17.00M | - | 0.0000 | 0.0000 | 33.10M | | CapEx | - | - | - | - | - |